Connect with us
ORCHPHARMA

Orchid Pharma Limited (ORCHPHARMA) Stock Analysis

Orchid Pharma Limited develops and manufactures generic injectables, oral solids, and APIs for regulated and emerging markets. It has expertise in cephalosporins and sterile formulations. The company supplies global generics players and institutions. It is listed on Indian stock exchanges after restructuring of its pharma operations.

Healthcare › Drug Manufacturers - Specialty & Generic
₹960.40
+8.59% 1W  |  +9.90% 52W
Market Cap
4.9k CR
P/E Ratio
127.9
52W High
₹1143.5
52W Low
₹480
Div. Yield
0%
Beta
0.6
50 DMA
₹941.7
200 DMA
₹826.4
Profit Margin
3.7%
Inst. Own.
17%
Trendline Analysis
🚀 BREAKOUT₹1.1k₹1.0k₹911.3₹803.5₹695.825 May02 Jul10 Aug23 Sep20 Nov32.6L
Fundamentals
Profit & Loss
MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales199221217244223217237263298207368304341
YoY Sales growth+20%+38%+3%+34%+12%-1%+9%+8%+34%-5%+55%+16%+14%
Expenses175185188212192191209269295206338290317
Operating Profit23352932302628-632301424
OPM %12%16%13%13%14%12%12%-2.1%1.0%0.8%8%4.6%7%
Other Income881388841212-28218
Interest4434344233224
Depreciation898899911119111111
Profit before tax20303028262219-71-1225327
Tax %0%0%-10%-1%0%0%-0%0%-11%0%0%3%-0%
Net Profit20293329272122-6-1-1326329
EPS in Rs3.905.806.505.795.374.104.39-1.12-0.18-2.495.090.634.77
Growth — CAGR
Metric3Y5Y10Y
Revenue CAGR23.0%22.0%4.0%
Profit CAGR53.0%17.0%8.0%
Shareholding Pattern
Promoters74.45%
FIIs0.93%
DIIs17.44%
Public7.17%
ORCHPHARMA
Holdings Analysis
Key strengths & risk signals
68
Overall
57
Fundamental
79
Technical
Risks (2)
Cannot calculate PEG - insufficient growth data.
POSITIVE YEAR! Stock gained 9.9% in the last year.
Strengths (3)
BULLISH TREND! 50-day average (941.7) is above 200-day average (826.4) - positive signal.
BULLISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 252,164 vs down days: 77,042. Ratio: 3.27x
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
Fundamental & Technical Analysis
68Overall
57Fundamental
79Technical
Fundamental Breakdown
Growth Quality
17/30
Revenue CAGR: 22.3% (EXCELLENT, 15/15). Profit CAGR: -40.1% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 3.7% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 5.54% public ownership - strong promoter/institutional control.
Stability Index
4/10
CAREFUL! Company does not have stable profit track. 3 loss-making quarters detected.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (941.7) is above 200-day average (826.4) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (960.4) is above both moving averages.
Trend Pattern
10/20
AT RESISTANCE! Stock is at key resistance level.
52W Performance
4/10
POSITIVE YEAR! Stock gained 9.9% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 252,164 vs down days: 77,042. Ratio: 3.27x
RSI
3/5
NEUTRAL! RSI at 52.8 - balanced momentum.
52W Range
4/5
UPPER HALF! Trading at 72.4% of 52W range - positive territory.
Momentum
3/5
MIXED MOMENTUM! Price growth is inconsistent - 8.6% (1 week), 7.5% (1 month), -3.8% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
ORCHPHARMA
Concall / Investor Presentation
Earnings call transcripts & AI summaries
QuarterConcallSummary
Q2FY272026-11-20Concall PDF
Q1FY272026-08-24Concall PDF
Q4FY262026-06-01Concall PDF
Q3FY262026-02-16Concall PDF
Q2FY262025-11-17Concall PDF

Peer Comparison

Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
Industry peers
StockPriceP/EProfit MarginRevenue CAGR 5YProfit CAGR 5Y52W ChangeStock StrengthTrendlineYoY ProfitQoQ ProfitYoY RevenueQoQ Revenue
ORCHPHARMA₹960.40127.93.7%22.3%-40.1%+9.9%68 APPROACHING RESISTANCE-156.1%-86.6%+15.6%+28.0%
MOREPENLAB₹90.2026.38.2%8.4%34.9%+106.0%69 BREAKDOWN+117.4%+57.6%+81.4%+30.9%
GUJTHEM₹352.70184.711.2%3.8%-7.0%-14.2%47 CONSOLIDATING DOWN-196.5%-224.3%+18.0%+13.9%
AARTIDRUGS₹484.5019.38.0%-2.3%5.4%+13.2%67 BREAKOUT+83.0%+65.1%+26.6%+17.6%
KPL₹4,128.4052.915.4%14.0%35.0%+19.1%66 HIT RESISTANCE+105.7%+13.3%+62.9%+11.5%
NOVARTIND₹1,722.4043.526.4%-1.4%-3.4%+177.5%65 BREAKDOWN–-340.7%–-46.1%
GUFICBIO₹418.2053.67.8%6.1%-6.9%+23.2%55 CONSOLIDATING DOWN+39.9%+5.4%+21.6%+10.5%
RPGLIFE₹2,540.9037.914.3%11.3%19.4%+12.5%73 BREAKDOWN–-13.6%–+8.1%
Data from TradeAlone · Updated daily